Stopped early
Opioid-Free Pain Control Regimen Following Robotic Radical Prostatectomy
NCT05597878 · Wake Forest University Health Sciences · Updated 15 June 2026
- What is being tested
- Oxycodone; Acetaminophen; Ketamine; Ketorolac; Acetaminophen
- For
- Pain Management; Opioid Use; Prostate Cancer
- Kind of study
- Tests a treatment or device on volunteers. Phase 2 and Phase 3.
- Who can join
- Ages 40 years to 75 years. About 58 people. The full rules are on the registry page.
- Where
- United States
- When
- Starts or started 18 April 2023, ends 26 Feb 2026. Registered 28 Oct 2022.
- Results
- None posted yet.
In the researchers' words
The objective of this study is to conduct a randomized clinical trial to evaluate an opioid versus an opioid-free pathway of perioperative use of ketamine, ketorolac, and IV acetaminophen followed by the postoperative use of ketorolac, and oral acetaminophen for pain associated with robotic-assisted radical prostatectomy. Escalation to use of opioid treatment for the opioid-free constituents will be available if needed.
Sites
- Atrium Health Wake Forest Baptist Comprehensive Cancer CenterWinston-Salem, North Carolina, United States